Compugen Ltd. (CGEN) Stock

Compugen Ltd. (CGEN) is a Healthcare stock trading at $2.00 (as of 2026-06-18), with a market capitalization of $248.67M and a trailing P/E of 5.4. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Compugen Ltd. researches, develops, and commercializes antibody-based therapeutics, including immuno-oncology candidates such as COM701, COM902, Bapotulimab, and AZD2936. The company operates research activities in Israel and conducts development and related activities in the United States and Europe, including collaborations with partners such as Bayer Pharma AG.

Valuation — source: SEC EDGAR (first-party)
Price$2.00
Market Cap$248.67M
P/E Ratio5.4
EV / EBITDA3.2
Price / Book1.88
Price / Sales2.65
DCF Value (model)$6.60
DCF Upside vs Price229.2%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$72.76M
Net Margin48.6%
Return on Equity34.4%
Current Ratio6.56
Revenue Growth (YoY)161.1%
EPS Growth (YoY)-337.5%
FCF Growth (YoY)-36.7%
Financial Health — source: SEC EDGAR
Altman Z-Score0.14 (distress)
Valuation vs Sector & Industry
Stock P/E5.4
Sector P/E (Healthcare)20.9
Industry P/E (Pharmaceutical Products)17.0
vs Sector-74.3%
vs Industry-68.4%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderSILVERARC CAPITAL MANAGEMENT, LLC ($7.06M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOEran Ophir
Employees74
CountryIL
IPO Date2000-08-11

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Protalix BioTherapeutics, Inc. (PLX)
  • Corbus Pharmaceuticals Holdings, Inc. (CRBP)
  • Alpha Cognition Inc. Common Stock (ACOG)
  • Seres Therapeutics, Inc. (MCRB)
  • Actuate Therapeutics Inc (ACTU)
  • Elicio Therapeutics, Inc. (ELTX)
  • Opus Genetics, Inc. (IRD)
  • Black Diamond Therapeutics, Inc. (BDTX)
CGEN earnings history · CGEN institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.